Expression of Glutathione S-transferase-pi (GST-pi) and Metallothionein (MT) in Lung Cancer.
スポンサーリンク
概要
- 論文の詳細を見る
It has been suggested that glutathione S-transferase-pi (GST-π) and metallothionein (MT), which are an intracellular detoxification enzyme and detoxification protein, are contribute to anti-cancer drug resistance. In present study, GST-π and MT expression was analyzed immunohistochemically in primary tumors from 97 patients with lung cancer and the relationship with the results of chemotherapy was examined. Of 56 previously untreated non-small cell lung cancer, 86% were positive for GST-π, which was significantly higher than the degree for small cell lung cancer (P<0.0001). All 8 previously untreated small cell lung cancer were negative for GST-π and 78% of 18 small celllung cancer cases receiving preoperative chemotherapy with a regimen including cisplatin were positive. GST-π was found to be induced after chemotherapy (P=0.0003). Of 56 previously untreated non-small cell lung cancers 27% were positive for MT and 80% of 15 non-small cell lung cancer received preoperative chemotherapy were positive. MT was significantly induced after chemotherapy (P=0.0005). We therefore suggest that GST-π is an important tumor marker of non-small cell lung cancer, which is significantly induced after chemotherapy and related to drug resistance.
- 特定非営利活動法人 日本肺癌学会の論文
特定非営利活動法人 日本肺癌学会 | 論文
- 診療科からみた新しいTNM病期分類(UICC-7)の問題点と課題?画像診断からみた問題点と課題?
- 新潟県における肺がんの解析
- 慢性血栓塞栓性肺高血圧症合併肺腺癌に対する左上葉切除術を施行した1例
- 肺がん検診における判定基準の改訂(2):B,C,D判定に関して
- 片側性多発脳神経障害(Garcin症候群)を契機に発見され,化学療法により神経症状の改善を得た小細胞肺癌の1例